Science implants PRIMA in first Stargardt's disease patient
What happened
TechCrunch reported on October 14 that Science Corporation has implanted its vision-restoring chip PRIMA in the first patient with Stargardt's disease. The surgery took place in May at Sydney Eye Hospital in Australia. The patient saw letters during the first rehabilitation session and read a word in the second. PRIMA is already approved in Europe for patients with geographic atrophy. The implant measures 2mm by 2mm, works with camera glasses, and currently provides only black-and-white, high-contrast central vision.
Written by AI from the coverage · updated 2 hours ago
Coverage
Follow the reports to see the story from different sides.
- TechCrunch · AIScience Corporation implants its vision-restoring chip in its first Stargardt disease patient
Science Corporation 已将视力恢复芯片 PRIMA 植入首例 Stargardt 病患者体内，该患者于 5 月在澳大利亚悉尼眼科医院接受手术。患者首次康复训练中看到字母，第二次能读出一个单词。PRIMA 已在欧洲获批用于地图样萎缩患者，设备为 2mm×2mm 植入体，配合摄像头眼镜使用，目前仅提供黑白高对比度中央视野。
Heat over time
Not enough continuous observations to draw a trend yet.